SG&A at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about TransMedics Group, Inc.'s sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TransMedics Group, Inc.'s SG&A?
- TransMedics Group, Inc. (TMDX) reported SG&A of $62.99M in Q1 2026.
- How has TransMedics Group, Inc.'s SG&A changed year-over-year?
- TransMedics Group, Inc.'s SG&A increased by 44.4% year-over-year, from $43.63M to $62.99M.
- What is the long-term trend for TransMedics Group, Inc.'s SG&A?
- Over 4 years (2021 to 2025), TransMedics Group, Inc.'s SG&A has grown at a 48.3% compound annual growth rate (CAGR), from $38.28M to $185.17M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.